| Patents for C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132) |
|---|
| 04/06/2006 | US20060074072 2-[3-(4-chlorophenyl)ureido] N-[4-(2-oxo-2H-pyridin-1-yl)phenyl]-4-methanesulfonylbutyramide; prophylaxis and/or therapy of thromboembolic diseases and for the treatment of tumors |
| 04/05/2006 | EP1173427B1 Hydroxamic acid derivative |
| 04/05/2006 | EP1140846B1 Aspartic protease inhibitors |
| 04/05/2006 | CN1249038C Process for preparing aryl ether |
| 04/04/2006 | US7022845 Monomethylation of nitrogeneous heterocycles |
| 04/04/2006 | US7022703 Acetylenic compound useful in treating inflammatory disorders |
| 04/04/2006 | CA2256492C Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists |
| 03/30/2006 | US20060069253 Aryl-substituted heterocyclic enaminones |
| 03/30/2006 | US20060069091 E.g., 2-[2-carboxypropyl]-5-hydroxy-1,2-oxazin-3-one, more potent than desacetoxycephalosporin G; bactericides reacting irreversibly with the active site serine residue of the enzyme; enzyme inhibitors; mimetics; isocephalosporins; monocyclic beta-lactam antibiotics; antibiotic resistance |
| 03/30/2006 | US20060069088 Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors |
| 03/30/2006 | CA2577799A1 3- (2-acylamino-1-hydroxyethyl)- morpholine derivatives and their use as bace inhibitors |
| 03/29/2006 | EP1640373A1 Process for producing 3-acylaminobenzofuran-2-carboxylic acid derivative |
| 03/29/2006 | CN1753882A Ethynyl derivatives serving as factor XA inhibitors |
| 03/28/2006 | US7019127 Coupling of H-phosphonate with a nucleoside alcohol to form the diester; oxidation with sulfur transfer agent to form a phosphorothioate triester |
| 03/28/2006 | US7019006 Compounds useful as anti-inflammatory agents |
| 03/28/2006 | US7019003 Bactericides |
| 03/28/2006 | US7019000 administering nitrogen-sulfur compounds, e.g. 4,4-dithiodimorpholine to inhibit binding of the E6 protein by human papilloma virus; treatment of cervical cancer |
| 03/28/2006 | CA2120374C 9-[(substituted glycyl) amido]-6-(substituted)-5-hydroxy-6-deoxytetracyclines |
| 03/23/2006 | WO2006030299A1 Processes for the preparation of polymorphs of efavirenz |
| 03/23/2006 | WO2005040102A3 Novel compounds and their use as antidiabetic and hypolipidemic agents, process for their preparation and pharmaceutical compositions containing them |
| 03/23/2006 | US20060063769 Preventives/remedies for urinary disturbance |
| 03/23/2006 | US20060063765 5-[({[({(2S)-4-[(3,4-dichlorophenyl)methyl]-2-morpholinyl}methyl)amino]carbonyl}amino)methyl]-N-methyl-3-furancarboxamide; free of N-{[4-(3,4-dichlorobenzyl)morpholin-2-yl]methyl}-N'-(2-furylmethyl)urea; CCR3/chemokine recetptor/ antagonists |
| 03/23/2006 | DE102004045648A1 Neue Betamimetika zur Behandlung von Atemwegserkrankungen New beta-mimetics for the treatment of respiratory disorders |
| 03/23/2006 | CA2580131A1 Substituted aniline derivatives |
| 03/22/2006 | EP1635909A2 Treatment of amyloid- and epileptogenesis-associated diseases |
| 03/22/2006 | EP1140924B1 Piperazine derivatives |
| 03/22/2006 | CN1751034A Process for the preparation of bicyclic aromatic amino acids and intermediates thereof |
| 03/21/2006 | US7015323 Resistant to metabolism having improved half-life and/or clearance properties compared to corresponding carbamate compounds; for example, N-(2-chlorobenzoyl)-p-(morpholinothiocarbonyloxy)tyrosine; use to treat inflammatory diseases for example |
| 03/21/2006 | US7015219 3-aryl-hydroxybenzoxazines and 3, 4-dihydro-3-aryl-hydroxybenzoxazines as selective estrogen receptor beta modulators |
| 03/21/2006 | US7015217 Cyclic sulfone derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE) |
| 03/21/2006 | CA2183250C Prodrugs of morpholine tachykinin receptor antagonists |
| 03/21/2006 | CA2178949C Morpholine and thiomorpholine tachykinin receptor antagonists |
| 03/16/2006 | WO2006029079A2 Synthesis of a benzoxazinone |
| 03/16/2006 | WO2006028284A1 Morpholine compound |
| 03/16/2006 | WO2005111002A3 Substituted cycloalkyl derivatives for use in the treatment of respiratory diseases |
| 03/16/2006 | US20060058348 N-benzyl-3-phenyl-3-heterocyclyl-propionamide compounds as tachykinin and/or serotonin reuptake inhibitors |
| 03/16/2006 | US20060058300 Intermediates of bupropion metabolites synthesis |
| 03/16/2006 | US20060058299 N-2s-4-3,4-difluorobenzyl morpholin-2yl methyl -2-(3-methylsulphonyl amino!phenyl acetamide as ccr3 antagonist for the treatment of inflammatory conditions |
| 03/16/2006 | US20060058298 Inhibitors of histone deacetylase |
| 03/16/2006 | CA2578966A1 Synthesis of a benzoxazinone |
| 03/14/2006 | US7012081 Antiproliferative agents; skin disorders; vision defects; liver and kidney disorders |
| 03/14/2006 | CA2176567C 1,3-oxazin-4-one derivatives, process and intermediates for their preparation and their use as herbicides |
| 03/14/2006 | CA2103838C Novel 7-(substituted)-8-(substituted-9-[(substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines |
| 03/09/2006 | US20060052596 preventing or treating cancer or an inflammatory disorder by administering to a subject in need thereof one or more substituted heterocyclic compounds |
| 03/09/2006 | US20060052377 2-(Alpha-phenylthiobenzyl)morpholine derivatives, e.g., (4-fluorophenyl){[2-methoxyphenyl]thio}methyl)morpholine; serotonin and norepinephrine reuptake inhibitors |
| 03/09/2006 | US20060052376 Carboxamides |
| 03/09/2006 | CA2576830A1 Arylamine ketones, their preparation methods, the pharmaceutical compositions containing them and their use |
| 03/08/2006 | EP1632494A1 Vasopressin v1a antagonists |
| 03/08/2006 | EP1632477A1 Benzamide derivative or salt thereof |
| 03/08/2006 | EP1631560A2 C-fms kinase inhibitors |
| 03/08/2006 | EP1631557A1 Cyclic hydroxylamine as psychoactive compounds |
| 03/08/2006 | EP1631552A2 Method for synthesising heterocyclic compounds from thiourea derivates |
| 03/08/2006 | CN1745076A Malonamide derivatives as gamma-secretase inhibitors |
| 03/08/2006 | CN1743365A Ultraviolet radiation absorbents for thermoplastic polymers and methods of producing same |
| 03/02/2006 | WO2006023381A1 Pyrimidinone compounds |
| 03/02/2006 | WO2006023158A2 Mineralocorticoid receptor modulator compounds and methods, and pharmaceutical compositions containing these compounds |
| 03/02/2006 | WO2006021654A1 4-arylmorpholin-3-one derivatives, preparation and therapeutic use thereof |
| 03/02/2006 | WO2006021213A2 Vasopressin v1a antagonists |
| 03/02/2006 | US20060047116 Such as N-methyl(1-{2-[(1R,5S)-3-(2-methyl-1H-benzimidazol-1-yl)-8-azabicyclo[3.2.1]oct-8-yl]ethyl}-2,3-dihydro-1H-inden-1-yl)methanamine; chemokine receptor antagonists; prevention or treatment of a human T-cell leukemia/lymphoma virus infection |
| 03/02/2006 | US20060047115 Synthesis of a benzoxazinone |
| 03/02/2006 | CA2689274A1 Vasopressin via antagonists |
| 03/02/2006 | CA2688912A1 Vasopressin v1a antagonists |
| 03/02/2006 | CA2688865A1 Vasopressin v1a antagonists |
| 03/02/2006 | CA2573446A1 4-arylmorpholin-3-one derivatives, preparation and therapeutic use thereof |
| 03/01/2006 | CN1741996A Carboxamide derivatives and their use as factor XA inhibitors |
| 03/01/2006 | CN1741986A Amide derivatives and their use as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 |
| 03/01/2006 | CN1243754C New process for the production of 9-oxa-3,7-diazobicyclic(3.3.1) nonane |
| 02/23/2006 | WO2006018853A2 Novel polymorphs of efavirenz |
| 02/23/2006 | US20060041127 Method for the regioselective preparation of substituted benzo[g]quinoline-3-carbonitriles and benzo[g]quinazolines |
| 02/23/2006 | US20060040933 Antiinflammatory agents |
| 02/23/2006 | US20060040931 Benzomorpholine derivatives |
| 02/23/2006 | CA2576993A1 Bisaryl-sulfonamides |
| 02/22/2006 | EP1406622B1 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 02/22/2006 | CN1738807A Substituted aralkyl derivatives |
| 02/22/2006 | CN1738799A Methods for preparing phenylalkyne derivatives |
| 02/22/2006 | CN1736994A Azo hetercyle beta-elemene derivative and its preparation method and uses |
| 02/22/2006 | CN1736992A 6-aryloxymethyl-4-aryl-3-morpholone derivative and its preparation method |
| 02/22/2006 | CN1242990C Red light emitted compound used for organic electroluminous device and orgainic electroluminous device using same |
| 02/21/2006 | US7002022 treatment of neoplastic diseases that respond to inhibition of the vascular endothelial growth factor receptor tyrosine kinase activity; tumors, retinopathy, macular degeneration |
| 02/21/2006 | US7002010 Process for the preparation of morpholinones as light stabilizers |
| 02/21/2006 | US7001905 Substituted diarylamines as MEK inhibitors |
| 02/21/2006 | CA2250347C Piperazine and piperidine compounds with high affinity for dopamine-d2 and serotonin-5ht1a receptors |
| 02/21/2006 | CA2065986C 1-(pyrido[3,4-b]-1,4-oxazinyl-4-yl)-1h-indoles, intermediates and a process for their preparation, and their use as medicaments |
| 02/16/2006 | US20060035894 Phenyl[(2S)-4-(phenylmethyl)morpholin-2-yl]methanol; anxiolytic, antidepressant, cognition activator; rise in the concentration of that neurotransmitter within the synaptic cleft; psycological disorders, attention deficit hyperactivity disorder, obesity; deprotection |
| 02/15/2006 | EP1626046A1 Photochromic oxazine compounds and methods for their manufacture |
| 02/15/2006 | EP1625117A1 Novel phenoxazinone derivatives as enzyme substrates and use thereof as indictor in the detection of microorganisms with peptidase activity |
| 02/15/2006 | EP1487456B1 Benzenesulphonate salt of a morpholine urea derivative for use as a ccr-3 antagonist in the treatment of inflammatory conditions |
| 02/15/2006 | CN1735620A Pure levofloxacin hemihydrate and processes for preparation thereof |
| 02/15/2006 | CN1735603A Benzomorpholine derivatives |
| 02/15/2006 | CN1735602A Nile red light-emitting compound, method for producing nile red light-emitting compound, and light-emitting device |
| 02/15/2006 | CN1735599A 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands |
| 02/15/2006 | CN1733769A Pyridinebenzoxazine analog quinolone derivative and its preparation method and uses |
| 02/15/2006 | CN1733744A Process for producing benzoxazine derivative and production intermediate thereof |
| 02/14/2006 | CA2347298C Organic initiators and their use in the polymerization of unsaturated monomers |
| 02/09/2006 | WO2006015259A2 Compounds and compositions as modulators of steroid hormone nuclear receptors |
| 02/09/2006 | WO2006014207A1 Prostaglandin analogs |
| 02/09/2006 | WO2003090691A3 Method and compositions for identifying anti-hiv therapeutic compounds |
| 02/09/2006 | US20060030618 Vanilloid receptor ligands and their use in treatments |
| 02/09/2006 | US20060030561 2-Benzyl-2-hydroxy-4-methyl-4-phenylpentanoic acid (1-oxo-1,3-dihydroisobenzofuran-5-yl)amide for example; treating type II diabetes, obesity, hypertension, arteriosclerosis, or glaucoma |
| 02/09/2006 | CA2574737A1 Compounds and compositions as modulators of steroid hormone nuclear receptors |